Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$128.37 1.72 (1.36%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 50.01(B)
Last Volume: 1,778,975 Avg Vol: 1,913,734
52 Week Range: $75.49 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  487
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 214,480 283,298 303,316 571,262
Total Sell Value $28,881,982 $37,155,070 $39,545,240 $69,827,197
Total People Sold 7 12 14 16
Total Sell Transactions 14 29 47 80
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 2278
  Page 5 of 92  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Flynn Paul R EVP Global Revenue   •       –      –    2023-04-17 4 AS $120.00 $333,720 D/D (2,781) 52,112 -15%     
   Stern Sadie EVP Chief Human Resources Offi   •       –      –    2023-04-10 4 AS $112.35 $44,154 D/D (393) 83,252 -4%     
   Brown Micheal Jon EVP Chief Legal Officer   •       –      –    2023-04-03 4 AS $114.07 $413,490 D/D (3,612) 61,870 -3%     
   Sayer Kevin R President CEO and Chairman of   •       •      –    2023-04-03 4 AS $113.83 $2,382,069 D/D (20,812) 327,457 -3%     
   Pacelli Steven Robert EVP Managing Director Dexcom V   •       –      –    2023-03-23 4 AS $116.40 $633,449 D/D (5,442) 138,129 8%     
   Dolan Matthew Vincent SVP Corporate Strategy-Develop   •       –      –    2023-03-16 4 AS $115.00 $264,845 D/D (2,303) 33,569 14%     
   Flynn Paul R EVP Global Revenue   •       –      –    2023-03-13 4 AS $106.27 $295,643 D/D (2,782) 54,893 18%     
   Regan Barry J. EVP Operations   •       –      –    2023-03-13 4 AS $106.27 $213,603 D/D (2,010) 70,472 18%     
   Dolan Matthew Vincent SVP Corporate Strategy-Develop   •       –      –    2023-03-13 4 AS $106.27 $661,956 D/D (6,229) 35,872 18%     
   Flynn Paul R EVP Global Revenue   •       –      –    2023-03-10 4 D $111.40 $1,876,516 D/D (16,845) 57,675     -
   Brown Micheal Jon EVP Chief Legal Officer   •       –      –    2023-03-10 4 D $111.40 $536,052 D/D (4,812) 65,482     -
   Abbey Donald EVP Global Business Services I   •       –      –    2023-03-10 4 D $111.40 $1,299,915 D/D (11,669) 208,023     -
   Stern Sadie EVP Chief Human Resources Offi   •       –      –    2023-03-10 4 D $111.40 $681,205 D/D (6,115) 84,038     -
   Regan Barry J. EVP Operations   •       –      –    2023-03-10 4 D $111.40 $632,746 D/D (5,680) 72,482     -
   Sylvain Jereme M EVP Chief Financial Officer   •       –      –    2023-03-10 4 D $111.40 $1,071,436 D/D (9,618) 77,111     -
   Selvaraj Shelly Ramasamy SVP Chief Information Officer   •       –      –    2023-03-10 4 D $111.40 $720,974 D/D (6,472) 54,512     -
   Pacelli Steven Robert EVP Managing Director Dexcom V   •       –      –    2023-03-10 4 D $111.40 $1,299,915 D/D (11,669) 143,571     -
   Leach Jacob Steven EVP Chief Technology Officer   •       –      –    2023-03-10 4 D $111.40 $1,794,526 D/D (16,109) 290,377     -
   Balo Andrew K EVP Regulatory Strategy Clinic   •       –      –    2023-03-10 4 D $111.40 $1,300,026 D/D (11,670) 50,908     -
   Dolan Matthew Vincent SVP Corporate Strategy-Develop   •       –      –    2023-03-10 4 D $111.40 $691,119 D/D (6,204) 42,101     -
   Sayer Kevin R President CEO and Chairman of   •       •      –    2023-03-10 4 D $111.40 $4,176,349 D/D (37,490) 348,269     -
   Flynn Paul R EVP Global Revenue   •       –      –    2023-03-08 4 A $0.00 $19 D/D 18,776 74,520     -
   Sylvain Jereme M EVP Chief Financial Officer   •       –      –    2023-03-08 4 A $0.00 $22 D/D 21,769 86,729     -
   Abbey Donald EVP Global Business Services I   •       –      –    2023-03-08 4 A $0.00 $19 D/D 18,776 219,692     -
   Naganathan Girish EVP Chief Technology Officer   •       –      –    2023-03-08 4 A $0.00 $19 D/D 18,776 50,225     -
  2278 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 92
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us